The hair loss treatment landscape is full of noise. Products that promise regrowth without evidence. Supplements with no controlled trials. Clinics selling expensive procedures to people who do not need them.
This guide lists only interventions that have demonstrated efficacy in at least one controlled human study. It ranks them by the strength and consistency of evidence, not by marketing investment.
There are no miracles here. There are treatments that work, some that partially work, and some that require professional access. Knowing the difference is the first act of taking this seriously.
Tier 1: FDA-Approved First-Line Treatments
Finasteride 1mg (Oral)
How it works: Finasteride is a selective inhibitor of 5-alpha-reductase type 2, the enzyme that converts testosterone into DHT. It reduces serum DHT by approximately 60–70%. DHT is the primary driver of follicular miniaturisation in androgenetic alopecia.
Effectiveness: Approximately 90% of men who take finasteride consistently experience halted hair loss progression. Around 65% see measurable regrowth. These figures come from Merck’s original Phase III trials and have been replicated in independent studies.
Timeline: Results are visible at 6 months. Peak results at 18–24 months. The treatment must be continued indefinitely — stopping finasteride allows DHT levels to recover and miniaturisation to resume within 6–12 months.
Access: Prescription required in most countries. Increasingly available through telehealth services.
Side effects: Sexual side effects (reduced libido, erectile dysfunction) are reported in approximately 2–4% of users in clinical trials. The post-finasteride syndrome discussion in online communities significantly overstates the clinical risk, but side effects are real and should be discussed with a prescribing doctor.
Minoxidil 5% (Topical)
How it works: Minoxidil was originally developed as an antihypertensive drug. Its mechanism in hair regrowth is not fully understood, but it prolongs the anagen (growth) phase of the hair cycle, increases follicle size, and improves blood flow to the scalp.
Effectiveness: Approximately 60% of users see measurable improvement. Minoxidil is significantly more effective when combined with finasteride than when used alone — the two address complementary pathways.
Timeline: Initial shedding at weeks 2–6 (normal). New growth visible at 3–4 months. Best results at 12 months.
Access: Over the counter in most countries. Available in liquid solution and foam formulations.
Note: Minoxidil must be applied to a dry scalp. Application to a wet scalp reduces absorption by approximately 50%.
Tier 2: Gold Standard Combination
Finasteride + Minoxidil
Multiple head-to-head trials have shown that the combination of oral finasteride and topical minoxidil produces superior outcomes compared to either treatment used alone. The mechanism is additive: finasteride addresses the root hormonal cause (DHT suppression) while minoxidil stimulates follicular activity and prolongs growth cycles.
For anyone who can tolerate and access both treatments, this is the most evidence-supported protocol available without a specialist consultation.
Tier 3: Evidence-Backed Adjuncts
Microneedling + Minoxidil
A randomised controlled trial published in the Journal of Cutaneous and Aesthetic Surgery compared 100 patients receiving minoxidil alone versus minoxidil plus weekly microneedling. The microneedling group showed more than twice the hair count improvement after 12 weeks.
The mechanism involves two pathways: microneedling increases scalp permeability (enhancing minoxidil absorption), and the micro-injuries trigger growth factor release — particularly VEGF and Wnt signalling proteins that support anagen phase initiation.
Protocol: 0.6–1.0mm roller or dermapen, once weekly. Do not apply minoxidil for 24 hours after needling.
Tretinoin 0.01% + Minoxidil
Approximately 40% of people do not respond to minoxidil alone. A significant reason is insufficient scalp expression of sulfotransferase — the enzyme that converts topical minoxidil into its active form, minoxidil sulfate.
Tretinoin (a vitamin A derivative) upregulates sulfotransferase in the scalp, rescuing a meaningful proportion of non-responders. A controlled study found that the addition of tretinoin converted 43% of minoxidil non-responders into responders.
Typically available as a compounded topical (0.01% tretinoin + 5% minoxidil). Prescription required in most countries.
Ketoconazole 2% Shampoo
Ketoconazole reduces local scalp DHT through a mild anti-androgenic mechanism and controls seborrheic dermatitis — a form of scalp inflammation that is frequently co-present in androgenetic alopecia and that amplifies follicular stress.
As a standalone treatment, evidence for regrowth is weak. As an adjunct to finasteride and minoxidil, it contributes meaningfully to the scalp environment.
Protocol: 2–3 times per week, leave on scalp for 3–5 minutes before rinsing. Available over the counter in most pharmacies.
Tier 4: Off-Label Prescription Treatments
Oral Dutasteride
Dutasteride inhibits both type 1 and type 2 isoforms of 5-alpha-reductase, compared to finasteride which only inhibits type 2. This produces a more complete DHT reduction — approximately 90% versus finasteride’s 60–70%.
Multiple trials have found dutasteride superior to finasteride for hair count outcomes. It is approved for hair loss in South Korea and Japan; in most other countries it is used off-label.
The trade-off: The more complete DHT suppression comes with a longer half-life (approximately 5 weeks versus finasteride’s 6 hours). This means any side effects that do occur take longer to resolve after stopping the medication.
Access: Prescription required. Typically considered after finasteride has shown inadequate results at 12 months.
Oral Minoxidil (Low Dose)
Oral minoxidil bypasses the topical absorption variability that makes some people poor responders to topical application. When taken orally, minoxidil is converted to its active form (minoxidil sulfate) in the liver, producing a more consistent systemic response.
Studies using low doses (0.25–5mg daily) have shown results that consistently outperform topical minoxidil in direct comparisons, with an acceptable side effect profile at the lower end of the dose range.
Common side effects: Fluid retention, mild hypertrichosis (unwanted hair growth in other areas). These are dose-dependent and generally resolve by reducing the dose.
Access: Prescription required. Medical supervision is recommended, particularly for anyone with cardiovascular history.
Tier 5: Surgical and Professional Procedures
Hair Transplant (FUE/FUT)
The donor dominance principle: follicles from the back and sides of the scalp are genetically resistant to DHT. When transplanted to thinning areas, these follicles retain their resistance and produce permanent coverage — if they are paired with ongoing medical treatment to preserve existing hair.
A hair transplant without finasteride is a procedure that will require repeat procedures. The existing non-transplanted hairs will continue to thin without treatment, creating an unnatural contrast over time.
Effectiveness: High, for appropriate candidates with sufficient donor density. Not a solution for early-stage hair loss or for people with retrograde alopecia affecting the donor zones.
Low-Level Laser Therapy (LLLT)
LLLT devices (laser caps, laser combs) increase ATP production in follicular mitochondria and reduce inflammation. The standalone evidence is modest — improvement rates in clinical trials are real but not dramatic. As an adjunct to a finasteride + minoxidil protocol, LLLT contributes incremental benefit.
Availability: FDA-cleared devices are available for home use without prescription.
What Does Not Have Good Evidence
A brief and non-exhaustive list:
- Caffeine shampoos: Interesting in vitro data; no meaningful human trial evidence for regrowth
- Rosemary oil: One small study suggested equivalence to 2% minoxidil; not replicated; likely weak adjunct at best
- Most commercial “hair growth” supplements: If they are not in the evidence-based list above, they are probably not supported by adequate human data
- Platelet-Rich Plasma (PRP): Mixed trial results; potentially useful as adjunct; not first-line
Frequently Asked Questions
Do I need to take finasteride forever? Yes, if you want to maintain the results. Finasteride works by suppressing DHT. When you stop, DHT recovers and hair loss resumes. Most people on finasteride for more than 2 years who stop will see a return to pre-treatment loss patterns within 6–12 months.
Is minoxidil foam better than solution? The foam formulation has better cosmetic tolerability (less greasy, faster drying) and is preferred by many users. Both formulations have equivalent efficacy data. The foam contains propylene glycol, which causes scalp irritation in some people — the solution avoids this.
Can I start with just minoxidil? Yes. Some people choose to start with minoxidil to assess tolerability before adding finasteride. Minoxidil-only protocols do produce results, particularly when combined with microneedling. However, they do not address the underlying hormonal cause. For comprehensive treatment, finasteride is the most important intervention.
What if nothing works? Hair loss that does not respond to first-line treatment over 18–24 months warrants a dermatologist consultation. The differential at that point includes scar-forming alopecias, androgen insensitivity, underlying systemic conditions, and assessment for surgical candidacy.